In a joint post in the Center for Global Development’s (CGD) “Global Health Policy” blog, “the second in a series of three on the quality of PEPFAR’s HIV treatment programs,” Mead Over, a senior fellow at  CGD, and research assistant Yuna Sakuma examine “why some facilities do better than others [in reducing patient attrition over the course of the treatment cascade] and what factors contribute to treatment success.” They note that “the CDC has been collecting data at the facility level on three categories of the determinants of quality: the adequacy of input supplies (category 1) and the conformity to norms of managerial practice and clinical practice (categories 2 and 3),” and they discuss the data (11/26).